PALO ALTO, Calif., Dec. 17, 2015 /PRNewswire/ — AirXpanders Inc., a company developing novel technology for women undergoing tissue expansion for breast reconstruction following a mastectomy, today announced three key new hires as it prepares for a decision from the FDA in 2016. Following the filing of its de novo application with the FDA in November, the company […]

BOSTON and PALO ALTO, Calif., Oct. 20, 2015 /PRNewswire/ — AirXpanders’ successful XPAND pivotal trial data presented at the American Society of Plastic Surgeons (ASPS) Meeting on October 18, 2015 ASPS is the world’s largest specialty plastic surgery organization with >7,000 members comprising 94% of all board-certified plastic surgeons in the U.S. Primary endpoint of […]

Underway in Fort Lauderdale is the second phase of a clinical trial for a procedure that seeks to reduce the amount of time and pain experienced by breast cancer patients undergoing reconstructive surgery. It is one of only seven such trials in the country and the only one in Florida.[..]

1047 Elwell Court, Palo Alto CA 94303 USA Tel: +1 (650) 390 9000 Fax: +1 650 390 9007 www.airxpanders.com ASX ANNOUNCEMENT AirXpanders XPAND Pivotal Trial Meets Primary Endpoint PALO ALTO, CA, United States, 25 August 2015: AirXpanders Ltd. (ASX:AXP) a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® tissue […]

August 2015 Australian women are among the first in the world to be offered a revolutionary method of breast reconstruction. Breast implants have been around for over 50 years and they are the most common method of breast reconstruction following a mastectomy. However, for many women implant reconstruction can be a painful and drawn out […]

Please visit clinicaltrials.gov to see updated information about AirXpanders clinical trial (NCT01425268) in progress. Once the clinicaltrials.gov site pulls up, please type AirXpanders into the search box and you will be connected to the XPAND tria l information posted there.

Patient-Activated Controlled Expansion (PACE) for Breast Reconstruction Utilizing Controlled Carbon Dioxide Inflation: Confirmation of aFeasibility Study Tony F. Connell, MBBS, BSc, FRACS Subiaco, Western Australia, Australia Interim results from the study described in this paper have been presented at the 17th World Congress of the International Confederation for Plastic, Reconstructive and Aesthetic Surgery, Santiago, Chile, […]

Interim Results of AirXpanders’ Multi-Centered Randomized Controlled Trial Demonstrate Faster, Needle-Free Alternative to Saline Tissue Expanders Highly statistically significant improvement in expansion and total implant times compared to saline Interim results of the XPAND trial published in the April 2014 issue of Plastic and Reconstructive Surgery PALO ALTO, Calif. (April 15, 2014) – AirXpanders Inc., […]

World’s First Needle-Free, Patient-Controlled Tissue Expansion Device for Women Undergoing Breast Reconstruction Following Mastectomy Approved in Australia
Australia represents the first commercial market for AirXpanders’s AeroForm®
Company to launch AeroForm to select plastic surgeons